Status:
UNKNOWN
Role of Calcium Binding Protein S100A12 in Diagnosis and Prognosis of Kawasaki Disease
Lead Sponsor:
The First Affiliated Hospital of Yangtze University
Conditions:
Diagnoses Disease
Eligibility:
All Genders
Brief Summary
Recent studies showed that the value of c100A12 increased in children with Kawasaki disease, and decreased rapidly after treatment with gamma globulin. In kawasaki disease with coronary artery dilatat...
Detailed Description
S100A12 was determined using the ELISA kit and according to the instructions.
Eligibility Criteria
Inclusion
- ▪Diagnostic criteria of Kawasaki disease revised by the American Heart Association in 2017
Exclusion
- Scarlet fever
- Drug allergy syndrome
- Stevens-Johnson syndrome
- Toxic shock syndrome
- Adenovirus infection
- Epstein-Barr(EB) virus infection
Key Trial Info
Start Date :
July 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 30 2023
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT05434611
Start Date
July 1 2022
End Date
December 30 2023
Last Update
June 28 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.